S-11/A Filing

MANHATTAN BRIDGE CAPITAL, INC CIK: 1080340

Filing Information

Form Type	S-11/A
Accession Number	`0001144204-16-087650`
Period End Date	20151231
Filing Date	20160311
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	loan-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 38 Cash Flow Statement 61 Stockholders Equity 19

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.02M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$47.68K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.84K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short term loans receivable	`ShortTermLoansReceivable`	$20.20M	USD	Point-in-time
Short term loans receivable	`ShortTermLoansReceivable`	$19.14M	USD	Point-in-time
Interest receivable on loans	`InterestReceivableCurrent`	$382.57K	USD	Point-in-time
Interest receivable on loans	`InterestReceivableCurrent`	$213.77K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	25.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	25.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$32.87K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.44M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	6.26M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$27.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.43M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	6.08M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.26M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$20.72M	USD	Point-in-time
Long term loans receivable	`LongTermLoansReceivable`	$4.89M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	177,000.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	177,000.00	shares	Point-in-time
Long term loans receivable	`LongTermLoansReceivable`	$10.71M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$19.09K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$8.77K	USD	Point-in-time
Security deposit	`SecurityDeposit`	$6.82K	USD	Point-in-time
Security deposit	`SecurityDeposit`	$6.82K	USD	Point-in-time
Investment in privately held company	`CostMethodInvestments`	$65.00K	USD	Point-in-time
Investment in privately held company	`CostMethodInvestments`	$50.00K	USD	Point-in-time
Investment in privately held company	`CostMethodInvestments`	$65.00K	USD	Point-in-time
Investment in privately held company	`CostMethodInvestments`	$50.00K	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$32.50K	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$164.51K	USD	Point-in-time
Total assets	`Assets`	$31.66M	USD	Point-in-time
Total assets	`Assets`	$24.44M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$11.82M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$7.70M	USD	Point-in-time
Short term loans	`ShortTermBorrowings`	$2.47M	USD	Point-in-time
Short term loans	`ShortTermBorrowings`	$1.10M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$99.64K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$163.62K	USD	Point-in-time
Deferred origination fees	`DeferredOriginationFees`	$279.68K	USD	Point-in-time
Deferred origination fees	`DeferredOriginationFees`	$244.78K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	-	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$617.44K	USD	Point-in-time
Total liabilities, all current	`LiabilitiesCurrent`	$10.58M	USD	Point-in-time
Total liabilities, all current	`LiabilitiesCurrent`	$13.91M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares - $.01 par value; 5,000,000 shares authorized; no shares issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares - $.01 par value; 5,000,000 shares authorized; no shares issued	`PreferredStockValue`	-	USD	Point-in-time
Common shares - $.001 par value; 25,000,000 authorized; 7,441,039 and 6,260,689 issued; 7,264,039 and 6,083,689 outstanding	`CommonStockValue`	$7.44K	USD	Point-in-time
Common shares - $.001 par value; 25,000,000 authorized; 7,441,039 and 6,260,689 issued; 7,264,039 and 6,083,689 outstanding	`CommonStockValue`	$6.26K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$18.50M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$14.12M	USD	Point-in-time
Treasury stock, at cost - 177,000	`TreasuryStockValue`	$369.33K	USD	Point-in-time
Treasury stock, at cost - 177,000	`TreasuryStockValue`	$369.33K	USD	Point-in-time
(Accumulated deficit) Retained earnings	`RetainedEarningsAccumulatedDeficit`	$113.35K	USD	Point-in-time
(Accumulated deficit) Retained earnings	`RetainedEarningsAccumulatedDeficit`	$-395.71K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$8.89M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$17.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$13.87M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$24.44M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$31.66M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Interest income from loans	`InterestIncomeFromLoans`	$2.40M	USD	Annual
Interest income from loans	`InterestIncomeFromLoans`	$3.36M	USD	Annual
Origination fees	`OriginationFees`	$502.51K	USD	Annual
Origination fees	`OriginationFees`	$644.71K	USD	Annual
Total Revenue	`Revenues`	$2.90M	USD	Annual
Total Revenue	`Revenues`	$4.00M	USD	Annual
Interest and amortization of debt service costs	`InterestAndAmortizationOfDebtServiceCosts`	$563.37K	USD	Annual
Interest and amortization of debt service costs	`InterestAndAmortizationOfDebtServiceCosts`	$691.39K	USD	Annual
Referral fees	`ReferralFees`	$2.24K	USD	Annual
Referral fees	`ReferralFees`	$2.36K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$876.91K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.04M	USD	Annual
Total operating costs and expenses	`OperatingCostsAndExpenses`	$1.44M	USD	Annual
Total operating costs and expenses	`OperatingCostsAndExpenses`	$1.73M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$2.27M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$1.46M	USD	Annual
Other income (Note 5)	`OtherNonoperatingIncome`	-	USD	Annual
Other income (Note 5)	`OtherNonoperatingIncome`	$21.20K	USD	Annual
Impairment loss on property and equipment (Note 6)	`ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss`	$13.86K	USD	Annual
Impairment loss on property and equipment (Note 6)	`ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss`	-	USD	Annual
Loss on write-down of investment in privately held company (Note 7)	`CostmethodInvestmentsOtherThanTemporaryImpairment`	$15.00K	USD	Annual
Loss on write-down of investment in privately held company (Note 7)	`CostmethodInvestmentsOtherThanTemporaryImpairment`	-	USD	Annual
Total other (loss) income, net	`NonoperatingIncomeExpense`	$21.20K	USD	Annual
Total other (loss) income, net	`NonoperatingIncomeExpense`	$-28.86K	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.48M	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.24M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$27.84K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$1.59K	USD	Annual
Net income	`NetIncomeLoss`	$2.24M	USD	Annual
Net income	`NetIncomeLoss`	$1.45M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.33	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.29	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.29	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.33	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	6.76M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	5.03M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	6.79M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.06M	shares	Annual

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net Income	`NetIncomeLoss`	$2.24M	USD	Annual
Net Income	`NetIncomeLoss`	$1.45M	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$39.54K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Depreciation	`Depreciation`	-	USD	Annual
Depreciation	`Depreciation`	$5.71K	USD	Annual
Non cash compensation expense	`ShareBasedCompensation`	$13.66K	USD	Annual
Non cash compensation expense	`ShareBasedCompensation`	$28.77K	USD	Annual
Impairment loss on property and equipment (Note 6)	`ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss`	$13.86K	USD	Annual
Impairment loss on property and equipment (Note 6)	`ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss`	-	USD	Annual
Loss on write-down of investment in privately held company (Note 7)	`CostmethodInvestmentsOtherThanTemporaryImpairment`	$15.00K	USD	Annual
Loss on write-down of investment in privately held company (Note 7)	`CostmethodInvestmentsOtherThanTemporaryImpairment`	-	USD	Annual
Interest receivable on loans	`IncreaseDecreaseInAccruedInterestReceivableNet`	$42.28K	USD	Annual
Interest receivable on loans	`IncreaseDecreaseInAccruedInterestReceivableNet`	$168.81K	USD	Annual
Other current and non current assets	`IncreaseDecreaseInOtherOperatingAssets`	$5.87K	USD	Annual
Other current and non current assets	`IncreaseDecreaseInOtherOperatingAssets`	$8.63K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$106.56K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-63.98K	USD	Annual
Deferred origination fees	`IncreaseDecreaseInDeferredOriginationFees`	$-34.91K	USD	Annual
Deferred origination fees	`IncreaseDecreaseInDeferredOriginationFees`	$-112.76K	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-373.22K	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	-	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$2.12M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$1.28M	USD	Annual
Issuance of short term loans	`IssuanceOfShortTermLoans`	$21.61M	USD	Annual
Issuance of short term loans	`IssuanceOfShortTermLoans`	$22.59M	USD	Annual
Collections received from loans	`ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment`	$13.25M	USD	Annual
Collections received from loans	`ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment`	$14.74M	USD	Annual
Proceeds from exercise of option (Note 5)	`ProceedsFromSaleOfRealEstateHeldforinvestment`	-	USD	Annual
Proceeds from exercise of option (Note 5)	`ProceedsFromSaleOfRealEstateHeldforinvestment`	$146.82K	USD	Annual
Purchase of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.09K	USD	Annual
Purchase of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.26K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-6.88M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-9.21M	USD	Annual
Proceeds from loans and line of credit, net	`ProceedsFromLinesOfCredit`	$2.75M	USD	Annual
Proceeds from loans and line of credit, net	`ProceedsFromLinesOfCredit`	$3.50M	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$134.66K	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$55.23K	USD	Annual
Proceeds from public offering, net	`ProceedsFromIssuanceOfCommonStock`	$4.24M	USD	Annual
Proceeds from public offering, net	`ProceedsFromIssuanceOfCommonStock`	$4.29M	USD	Annual
Proceeds from public offering, net	`ProceedsFromIssuanceOfCommonStock`	$4.24M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$2.13M	USD	Annual
Dividends paid	`PaymentsOfDividends`	$853.50K	USD	Annual
Deferred financing costs incurred	`PaymentsOfFinancingCosts`	$32.50K	USD	Annual
Deferred financing costs incurred	`PaymentsOfFinancingCosts`	$171.55K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$4.82M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$6.96M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$59.16K	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-973.35K	USD	Annual
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.02M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$47.68K	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$106.84K	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$1.02M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$47.68K	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$106.84K	USD	Point-in-time
Taxes paid during the year	`IncomeTaxesPaid`	$56.00	USD	Annual
Taxes paid during the year	`IncomeTaxesPaid`	$416.08K	USD	Annual
Interest paid during the year	`InterestPaid`	$563.37K	USD	Annual
Interest paid during the year	`InterestPaid`	$596.19K	USD	Annual
Dividend declared and payable	`DividendsPayableCurrent`	-	USD	Point-in-time
Dividend declared and payable	`DividendsPayableCurrent`	$617.44K	USD	Point-in-time

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$8.89M	USD	Point-in-time
Balance	`StockholdersEquity`	$17.74M	USD	Point-in-time
Balance	`StockholdersEquity`	$13.87M	USD	Point-in-time
Non cash compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$13.66K	USD	Annual
Non cash compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$28.77K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$61.19K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$55.23K	USD	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$73.47K	USD	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	-	USD	Annual
Public offering	`StockIssuedDuringPeriodValueNewIssues`	$4.29M	USD	Annual
Public offering	`StockIssuedDuringPeriodValueNewIssues`	$4.24M	USD	Annual
Dividends paid	`Dividends`	$853.50K	USD	Annual
Dividends paid	`Dividends`	$2.13M	USD	Annual
Dividends declared and payable	`DividendsCash`	$617.44K	USD	Annual
Net income for the year ended	`NetIncomeLoss`	$2.24M	USD	Annual
Net income for the year ended	`NetIncomeLoss`	$1.45M	USD	Annual
Balance	`StockholdersEquity`	$8.89M	USD	Point-in-time
Balance	`StockholdersEquity`	$17.74M	USD	Point-in-time
Balance	`StockholdersEquity`	$13.87M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.